Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Director effectiveness assessment

13 Feb 2020 07:00

RNS Number : 8370C
Barclays PLC
13 February 2020
 

 

13 February 2020

Barclays PLCBarclays Bank PLC

Director effectiveness assessment: disclosure of regulatory investigation

In accordance with the UK Corporate Governance Code, all of the current Directors of Barclays PLC will be submitting themselves for election or re-election at the Annual General Meeting to be held on 7 May 2020, and will be unanimously recommended by the Board for election or re-election as appropriate. Further information in this regard will be set out in the Notice of Meeting which will be published in due course.

In deciding whether to recommend Jes Staley for re-election, the Board has carried out its usual formal and rigorous performance assessment, which it does in respect of the effectiveness of each of the Directors. As part of its determination in respect of Mr. Staley, the Board has had regard to media reports in the past 6 months that have highlighted historical links between Mr. Staley and Jeffrey Epstein.

As has been widely reported, earlier in his career Mr. Staley developed a professional relationship with Mr. Epstein. In the summer of 2019, in light of the renewed media interest in the relationship, Mr. Staley volunteered and gave to certain executives, and the Chairman, an explanation of his relationship with Mr. Epstein. Mr. Staley also confirmed to the Board that he has had no contact whatsoever with Mr. Epstein at any time since taking up his role as Barclays Group CEO in December 2015.

The relationship between Mr. Staley and Mr. Epstein was the subject of an enquiry from the Financial Conduct Authority ("FCA"), to which the Company responded. The FCA and the Prudential Regulation Authority subsequently commenced an investigation, which is ongoing, into Mr. Staley's characterisation to the Company of his relationship with Mr. Epstein and the subsequent description of that relationship in the Company's response to the FCA.

Based on a review, conducted with the support of external counsel, of the information available to us and representations made by Mr. Staley, the Board (the Executive Directors having been recused) believes that Mr. Staley has been sufficiently transparent with the Company as regards the nature and extent of his relationship with Mr. Epstein. Accordingly, Mr. Staley retains the full confidence of the Board, and is being unanimously recommended for re-election at the Annual General Meeting.

The Board will continue to cooperate fully with the regulatory investigation, and will provide a further update as and when it is appropriate to do so.

- ENDS -

For further information, please contact:

Investor Relations

Media Relations

Adam Strachan

Tom Hoskin

+1 212 526 8442

+44 (0) 20 7116 4755

James Johnson 

+44 (0)20 7116 7233

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group.

For further information about Barclays, please visit our website home.barclays 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLLLFBLLBBBB
Date   Source Headline
26th Mar 20204:27 pmRNSNotice to Noteholders Series 11492 Class MV
11th Mar 20205:47 pmRNSPublication of Suppl.Prospcts
2nd Mar 20205:30 pmRNSPublication of Registration document
14th Feb 20204:00 pmRNSAnnual Report on Form 20-F
13th Feb 20207:00 amRNSAnnual Financial Report
13th Feb 20207:00 amRNSDirector effectiveness assessment
23rd Dec 20197:00 amRNSExtension of Maturity Date Class OU & Class OV
16th Dec 20197:17 amRNSDirectorate Change
6th Dec 20195:40 pmRNSNotice to Covered Bondholders
5th Dec 20195:50 pmRNSNotice to Covered Bondholders
5th Dec 20197:00 amRNSResults of offering of shares in Sophos Group plc
4th Dec 20194:35 pmRNSProposed offering of shares in Sophos Group plc
21st Nov 20197:00 amRNSResults of offering of shares in Sophos Group plc
20th Nov 20194:35 pmRNSProposed offering of shares in Sophos Group plc
24th Oct 20195:33 pmRNSPublication of Suppl.Prospcts
21st Oct 20191:50 pmRNSPublication of Final Terms
17th Oct 20197:00 amRNSNotice of Redemption - Holders of 6.3688% PRCI
14th Oct 20196:31 pmRNSPost Stabilisation Notice - no stabilisation
30th Sep 20192:34 pmRNSElection of Home Member State
26th Sep 20197:00 amRNSDirectorate and other Governance Changes
18th Sep 20198:51 amRNSBarclays PLC Pre-Stabilisation Notice
5th Sep 201910:54 amRNSPublication of Suppl.Prospcts
22nd Aug 20194:40 pmRNSDelisting Notice Series 11492 Class OD
13th Aug 20194:00 pmRNSPublication of Suppl.Prospcts
12th Aug 20191:49 pmRNSPublication of a Prospectus
1st Aug 20197:15 amRNSHalf-year Report
18th Jul 20195:21 pmRNSPublication of a Prospectus
12th Jul 201912:08 pmRNSPublication of GSSP Base Prospectus 16
3rd Jul 20197:00 amRNSPost Stabilisation Notice - Barclays PLC AT1
18th Jun 20192:10 pmRNSPublication of GSSP Base Prospectus 5
7th Jun 201911:08 amRNSNotice to Noteholders-Series 11492 Class NG
6th Jun 201910:04 amRNSPre Stabilisation Notice - Barclays PLC AT1
1st May 20199:16 amRNSBarclays PLC Pre-Stabilisation Notice
25th Apr 20197:00 amRNSRedemption Notice
18th Apr 20193:14 pmRNSNotice to Noteholders Series 11492 Class NA
18th Apr 20193:08 pmRNSNotice to Noteholders Series 11492 Class MS
12th Apr 20197:00 amRNSPublication of Suppl.Prospcts
12th Apr 20197:00 amRNSPublication of a Prospectus
9th Apr 20198:00 amRNSB Share Purchase Offer
25th Mar 201912:24 pmRNSPost Stabilisation Notice - Just Group plc
15th Mar 20195:15 pmRNSPublication of a Prospectus
14th Mar 201910:07 amRNSStabilisation Notice
11th Mar 20193:15 pmRNSPublication of Registration Document
7th Mar 201912:17 pmRNSBanco BPM Post-Stabilisation Notice
1st Mar 20198:40 amRNSBanco BPM - Pre-Stabilisation Notice
28th Feb 20193:37 pmRNSPublication of Final Terms
28th Feb 20193:36 pmRNSPublication of Final Terms
22nd Feb 20199:00 amRNSDirectorate Change
21st Feb 20195:30 pmRNSAnnual Report 2018 on Form 20-F
21st Feb 20192:00 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.